Pharmacokinetic and pharmacodynamic evaluations of a potent analgesic, dihydroetorphine, in hairless rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 2, 2001, Pages 528-536

  Ohmori, Satoshi ^a   Hayashi, Teruaki ^a   Kawase, Masami ^a   Saito, Setsuo ^a   Morimoto, Yasunori ^a  

^a JOSAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DIHYDROETORPHINE; GLUCURONIDE; OPIATE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG METABOLISM; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; RAT STRAIN; TISSUE DISTRIBUTION;

ALGORITHMS; ANALGESICS, OPIOID; ANIMALS; BILE; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; BLOOD PROTEINS; CENTRAL NERVOUS SYSTEM; ETORPHINE; GLUCURONIDES; INJECTIONS, INTRAVENTRICULAR; PAIN MEASUREMENT; PROTEIN BINDING; RATS; RATS, INBRED STRAINS;

EID: 0035142078     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Brain and spinal cord distribution of biphalin: Correlation with opioid receptor density and mechanism of CNS entry
2. Etorphine: μ-Opioid receptor selective antinociception and low physical dependence capacity
3. Dihydroetorphine physical dependence and stereotype after continuous infusion in the rat
4. Synthesis of thebaine and oripavine from codeine and morphine
5. Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine
6. Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydro-oripavine series and derived analogs of N-allylnormorphine and -norcodeine
7. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat
8. The systemic bioavailability of buprenorphine by various routes of administration
9. Studies on transdermal delivery system of dihydroetorphine hydrochloride
10. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: Correlation with the interaction at the mu-opioid receptor
11. Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine
12. Transdermal penetration enhancers: Applications, limitations, and potential
13. Dermal metabolism
14. Pharmacodynamics and pharmacokinetics of dihydroetorphine hydrochloride administered sublingually in mice and rats
15. Antitussive effect of dihydroetorphine in mice
16. Agonist and antagonist properties of dihydroetorphine for μ-opioid receptors in mice
17. D with the opiate antagonist cyclofoxy: Equilibrium studies in the conscious rat
18. Using dihydroetorphine to control cancer pain
19. An epidemiological study on dihydroetorphine abuse
20. Anti-allodynic actions of intravenous opioids in the nerve injured rat: Potential utility of heroin and dihydroetorphine against neuropathic pain
21. Potent reinforcing effects of dihydroetorphine in rats
22. The effect of different routes of administration on the metabolism of morphine: The disposition of morphine and its metabolites after topical application
23. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine
24. Quantitative determination of dihydroetorphine in rat plasma and brain by liquid chromatography-tandem mass spectrometry
25. Transdermal delivery of a potent analgesic dihydroetorphine: Kinetic analysis of skin permeation and analgesic effect in hairless rat
26. Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats
27. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling
28. Pharmacodynamics and tolerance development during multiple intravenous bolus morphine administration in rats
29. Opioid analgesics and antagonists
30. 14C]antipyrine
31. Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studied
32. Transdermal fentanyl therapy: System design, pharmacokinetics and efficacy
33. Utility of topical formulations of morphine hydrochloride containing azone and N-methyl-2-pyrrolidone
34. Time course of etorphine levels in tissues of opiate tolerant and nontolerant rats
35. Physical dependence produced by dihydroetorphine in mice
36. Antinociceptive effect of dihydroetorphine following various routes of administration: A comparative study with morphine
37. An investigation on the situation of utilization of narcotic medications for cancer pain patients
38. Experimental therapeutic effects of dihydroetorphine in morphine-dependent rats and monkeys
39. Dihydroetorphine is a μ-receptor-selective ligand
40. Involvement of μ-opioid receptors and α-adrenoceptors in the immunomodulatory effects of dihydroetorphine
41. A new version of MULTI(ELS) for extended nonlinear least squares